| Financial Year |
March 31 2023 |
| Monetary Funds |
2,279,825,888.91 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,450,000.00 |
| Accounts Receivable |
1,435,141,386.97 |
| Advances to Suppliers |
22,081,613.57 |
| Other Receivables |
33,592,439.85 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
182,615,341.06 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
4,083,912.54 |
| Other Current Assets |
799,797,290.03 |
| Total Current Assets |
5,027,691,209.79 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
186,637,779.79 |
| Long-term Equity Investment |
405,460,482.86 |
| Investment Properties |
107,972,338.84 |
| Fixed Assetes |
1,642,696,312.37 |
| Under-construction Projects |
411,628,899.64 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
12,677,715,692.57 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
37,369,744.46 |
| Deferred Income Tax Assets |
241,387,324.37 |
| Other Non-Current Assets |
124,840,236.84 |
| Sub-Total of Non-Current Assets |
16,016,005,008.11 |
| Total Assets |
21,043,696,217.90 |
| Short-Term Loans |
643,407,888.02 |
| Trading Financial liabilities |
-- |
| Notes Payable |
55,634,876.35 |
| Accounts Payable |
1,251,944,301.19 |
| Accounts Received In Advance |
6,731,110.64 |
| Employee Compensation Payable |
40,526,096.38 |
| Taxes Payable |
127,028,020.03 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
200,403,639.45 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
392,664,895.41 |
| Other Current Liabilities |
150,000.00 |
| Sub-Total of Current Liabilities |
2,755,735,455.05 |
| Long-term Loans |
3,794,926,886.84 |
| Bonds Payable |
1,370,588,891.22 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,411,238,793.39 |
| Deferred Income Tax Liabilities |
261,682,350.61 |
| Other Non-Current Liabilities |
15,752,730.00 |
| Sub-Total of Non-Current Liabilities |
7,230,628,531.25 |
| Total Liabilities |
9,986,363,986.30 |
| Paid-In Capital(Or Share Stock) |
1,694,213,520.00 |
| Capital Surplus |
1,121,205,704.58 |
| Surplus Reserve |
489,507,065.16 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
6,396,447,518.61 |
| Minority Stockholder's Interest |
1,261,777,952.03 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
9,795,554,279.57 |
| Owner's Equity（Stockholder's Equity） |
11,057,332,231.60 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
21,043,696,217.90 |
